Complete classification of steerability under local filters and its relation with measurement incompatibility

Quantum steering is a central resource for one-sided device-independent quantum information. It is manipulated via one-way local operations and classical communication, such as local filtering on the trusted party. Here, we provide a necessary and sufficient condition for a steering assemblage to be transformable into another via local filtering. We characterize the equivalence classes with respect to filters in terms of the steering equivalent observables (SEO), first proposed to connect the problem of steerability and measurement incompatibility. We provide an efficient method to compute the extractable steerability that is maximal via local filters and show that it coincides with the incompatibility of the SEO. Moreover, we show that there always exists a bipartite state that provides an assemblage with steerability equal to the incompatibility of the measurements on the untrusted party. Finally, we investigate the optimal success probability and rates for transformation protocols (distillation and dilution) in the single-shot scenario together with examples

Safety-based Injection Strategy for Carbon Dioxide Geological Sequestration in a Deep Saline Aquifer with Complex Sandstone-shale Sequences: A Case Study from Taiwan

AbstractThe purpose of this study was to decide the best injection strategy for CO2 geo-sequestration in a deep saline aquifer with complex bedded sandstone-shale sequences. The best injection strategy is decided based on the estimates of the safety index (SFI). Numerical simulation method was used in this study. The major conclusions from this study are: (1) Safe trapping mechanisms contribute to a lower risk of CO2 leakage by trapping CO2 as immobile blobs or changing the phase of CO2 from supercritical phase to aqueous, ionic, and mineral phases in the post-injection period. (2) For an aquifer with complex sandstone-shale sequences, the best injection strategy should be decided by the results of risk evaluation and the SFI estimation. (3) The well location affected the injection strategy. The risk of CO2 leakage was lower using a down-dip injection well than an up-dip well. (4) The best strategy for this case study was to use the down-dip well to inject CO2 into the bottom sandstone layer. The SFI for this scenario reached 0.99 at the storage time of 1000 years, which meant that the probability of CO2 leakage occurring was nearly zero

Epidemiology and outcomes of anal abscess in patients on chronic dialysis: a 14-year retrospective study

OBJECTIVES: We conducted this retrospective study to elucidate the clinical presentation and outcomes of anal abscess in chronic dialysis patients. METHODS: We performed a chart review of patients who were hospitalized for anal abscess from Jan. 2002 to Dec. 2015. A total of 3,074 episodes of anal abscess were identified. Of these, 43 chronic dialysis patients with first-time anal abscess were enrolled. Patients were divided into a surgical group and a nonsurgical group according to the treatment received during hospitalization. The baseline characteristics, clinical findings, treatments and outcomes were obtained and analyzed. The endpoints of this study were in-hospital mortality, one-year mortality and one-year recurrence. RESULTS: Of the 43 patients, 27 (62.7%) received surgical treatment, and 16 (37.2%) received antibiotic treatment alone. There was no significant difference in age, sex, body mass index, smoking habits, comorbidities, or dialysis characteristics between the two groups. Perianal abscess was the most common type of anal abscess, and 39.5% of patients experienced fistula formation. Most patients had mixed aerobic and anaerobic flora. Our data demonstrate that there was no significant difference in hospital stay, one-year survival or recurrence rate between the surgical group and nonsurgical group. However, there was a trend toward better in-hospital survival in patients who received surgical treatment (p=0.082). CONCLUSION: In chronic dialysis patients with anal abscess, there was no statistically significant difference in clinical presentation and outcomes between the surgical and nonsurgical groups, although the surgical group had a trend of better in-hospital survival

Trends and predictors of changes in pulmonary function after treatment for pulmonary tuberculosis

OBJECTIVES: The present study aimed to investigate the trends in changes in pulmonary function and the risk factors for pulmonary function deterioration in patients with pulmonary tuberculosis after completing treatment. INTRODUCTION: Patients usually have pulmonary function abnormalities after completing treatment for pulmonary tuberculosis. The time course for changes in pulmonary function and the risk factors for deterioration have not been well studied. METHODS: A total of 115 patients with 162 pulmonary function results were analyzed. We retrieved demographic and clinical data, radiographic scores, bacteriological data, and pulmonary function data. A generalized additive model with a locally weighted scatterplot smoothing technique was used to evaluate the trends in changes in pulmonary function. A generalized estimating equation model was used to determine the risk factors associated with deterioration of pulmonary function. RESULTS: The median interval between the end of anti-tuberculosis treatment and the pulmonary function test was 16 months (range: 0 to 112 months). The nadir of pulmonary function occurred approximately 18 months after the completion of the treatment. The risk factors associated with pulmonary function deterioration included smear-positive disease, extensive pulmonary involvement prior to anti-tuberculosis treatment, prolonged anti-tuberculosis treatment, and reduced radiographic improvement after treatment. CONCLUSIONS: After the completion of anti-tuberculosis TB treatment, several risk factors predicted pulmonary function deterioration. For patients with significant respiratory symptoms and multiple risk factors, the pulmonary function test should be followed up to monitor the progression of functional impairment, especially within the first 18 months after the completion of anti-tuberculosis treatment